This profile hasn't yet passed our validation checks
Submit your email to push it up the queue
Bio-Thera Solutions, Ltd.
Bio-Thera Solutions, Ltd., headquartered in China, is a prominent biopharmaceutical company specialising in the development of innovative therapies for autoimmune diseases and oncology. Founded in 2010, the company has made significant strides in the industry, focusing on monoclonal antibodies and biosimilars that address unmet medical needs. With a strong presence in both domestic and international markets, Bio-Thera has established itself as a leader in the biopharmaceutical sector. Its core products, including the well-regarded BAT1806, exemplify the company's commitment to quality and efficacy, setting them apart from competitors. Recognised for its robust pipeline and strategic partnerships, Bio-Thera Solutions continues to enhance its market position, contributing to advancements in healthcare and improving patient outcomes globally.
DitchCarbon Score
How does Bio-Thera Solutions, Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Bio-Thera Solutions, Ltd.'s score of 30 is higher than 51% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Bio-Thera Solutions, Ltd.'s reported carbon emissions
In 2023, Bio-Thera Solutions, Ltd. reported total carbon emissions of approximately 42,696,000 kg CO2e for Scope 1 and about 56,542,000 kg CO2e for Scope 2, resulting in a combined total of around 99,238,000 kg CO2e. This marks a slight increase in emissions compared to 2022, where the company recorded approximately 42,433,000 kg CO2e for Scope 1 and 67,521,000 kg CO2e for Scope 2, leading to a total of about 109,954,000 kg CO2e. Over the past few years, Bio-Thera has shown a commitment to monitoring and reporting its emissions, although no specific reduction targets or initiatives have been documented. The company has not disclosed any Scope 3 emissions data, indicating a focus primarily on direct and indirect emissions from its operations. The emissions data is not cascaded from any parent organization, and all figures are sourced directly from Bio-Thera Solutions, Ltd. As the company continues to assess its carbon footprint, it remains essential for them to establish clear reduction targets to align with industry standards and climate commitments.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|
| Scope 1 | 38,202,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 93,417,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Bio-Thera Solutions, Ltd. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
